RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers tracked the in situ CAR-T cells to assess their effectiveness and safety.

University of Wisconsin-Madison researchers have developed nanoparticles that, in the lab, can activate immune responses to cancer cells. If they are shown to work as well in the body as they do ...

A new technique lets researchers make many more of the particles much faster, using consistent practices that meet safety ...

This means the nanoparticles, made from fat molecules, remain in the blood longer, and thus have a greater chance of bumping into freely moving cancer cells. There is an added advantage.

Although the respiratory system is one of the main entry points for microplastics and nanoplastics (MNPs) from the air into ...

University of Pittsburgh researchers have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy, according to a new Nature Nanotechnology study ...

Turning silver nanoparticles into commercial products could create a faster pathway to new antimicrobials and cancer treatments.

Lipid nanoparticles, made famous for their use in delivering messenger RNA in COVID-19 vaccines, have gained attention as carriers in cancer immunotherapy. Previous research focused on optimizing ...

Scientists were able to safely deploy ultrabright nanoparticles, which bind to and light up cancer cells, in five patients with metastatic melanoma at the Memorial Sloan Kettering Cancer Center in ...

The team's paper, "Cell-membrane coated nanoparticles for tumor delineation and qualitative estimation of cancer biomarkers at single wavelength excitation in murine and phantom models," is ...